Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia

2025-11-24T09:51:38-08:00November 24th, 2025|2025 Publications, Featured Publications, Publications|

Read more

QuANTUM-First: Clinical Validation of the LeukoStrat Companion Diagnostic for the Selection of Patients With Acute Myeloid Leukemia Harboring FMS-Like Tyrosine Kinase 3–Internal Tandem Duplications for Treatment With Quizartinib

2025-10-28T11:29:07-07:00September 3rd, 2025|2025 Publications, Featured Publications, Publications|

Read more

A Systematic, Evidence-Based Workflow for Classifying KMT2A Fusions in AML

2025-07-29T15:39:42-07:00July 29th, 2025|2025 Publications, Featured Publications, Publications|

Read more

Performance Comparison of Illumina^® MiSeq™ and MiSeq™ i100 Systems using Invivoscribe’s LymphoTrack^® Assays

2025-09-18T16:16:23-07:00May 27th, 2025|2025 Publications, Featured Publications, Publications|

Read more

From prognostication to precision in acute myeloid leukemia

2025-05-08T16:47:49-07:00May 8th, 2025|2025 Publications, Featured Publications, Publications|

Read more

Measurable residual disease and post-transplantation gilteritinib maintenance for patients with FLT3 ITD mutated AML

2025-05-09T09:20:30-07:00May 8th, 2025|2025 Publications, Featured Publications, Publications|

Read more